Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-005654
Filing Date
2017-05-22
Accepted
2017-05-22 15:02:11
Documents
53
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0317_americanbrivision.htm 10-Q 472652
2 CERTIFICATION f10q0317ex31i_american.htm EX-31.1 10712
3 CERTIFICATION f10q0317ex31ii_american.htm EX-31.2 11109
4 CERTIFICATION f10q0317ex32i_american.htm EX-32.1 3982
5 CERTIFICATION f10q0317ex32ii_american.htm EX-32.2 3817
  Complete submission text file 0001213900-17-005654.txt   2964415

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20170331.xml EX-101.INS 564413
7 XBRL SCHEMA FILE mtoo-20170331.xsd EX-101.SCH 30811
8 XBRL CALCULATION FILE mtoo-20170331_cal.xml EX-101.CAL 27120
9 XBRL DEFINITION FILE mtoo-20170331_def.xml EX-101.DEF 86245
10 XBRL LABEL FILE mtoo-20170331_lab.xml EX-101.LAB 196272
11 XBRL PRESENTATION FILE mtoo-20170331_pre.xml EX-101.PRE 176582
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 17860682
SIC: 2834 Pharmaceutical Preparations